The diagnosis and the reproductive and metabolic consequences of polycystic ovary syndrome

2018

Full text Open access: Gold Metadata (CSL-JSON)
DOI 10.5114/jogi.2018.79428
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

Polycystic ovary syndrome (PCOS) is the most common endocrine disorder affecting women in their reproductive age, with significant reproductive, metabolic and psychological implications.The PCOS is a multifactorial disorder involving interactions between certain genes, environmental factors, gonadotropin dysfunction, insulin resistance (IR) and hyperandrogenism.Different phenotypes of PCOS exist, based on the PCOS definition by NIH and ESHRE/ARM and the clinical presentation.A large proportion of PCOS women have high luteinizing hormone (LH) levels.Partly due to the increased LH stimulation there is increased ovarian androgen production.The high androgen levels were suggested as the main cause of ovarian follicle maturation arrest with subsequent infertility.In addition, insulin stimulates and maintains ovarian androgen secretion, which explains the association between hyperinsulinemia and the severity of hirsutism in PCOS.There is no ideal therapy that treats all features of PCOS, so the treatment is directed towards the clinical presentation (targeted therapy).